亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北遠成賽創科技有限公司孝感分公司  

原料藥制劑、醫藥中間體、香精香料

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:李孟剛
  • 電話:020-31067006
  • 郵件:ycyy11@yccreate.com
  • 傳真:020-23837900
  • QQ:2355327107
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > ***左氧氟沙星原料藥廠家
***左氧氟沙星原料藥廠家
單價 257.00 / kg對比
銷量 暫無
發貨 湖北武漢市付款后3天內
庫存 6581kg起訂1kg
品牌 南箭
過期 長期有效
更新 2014-12-17 14:16
 
詳細信息
***左氧氟沙星
中文別名:
;左氧氟沙星***;(3S)-(-)-9-氟-2,3-二氫-3-甲基-10-(4-甲基-1-哌嗪基)-7-氧-;7H-吡啶并[1,2,3-de]-[1,4]苯并噁嗪-6-羧酸***;左氟沙星·***;
英文名稱:
Levofloxacin Hydrochloride
英文別名:
;LEVOFLOXACIN HCL;carboxylic acid monohydrochloride;LevofloxacinHydrochloride;(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid monohydrochloride;
分子式:
C18H20FN3O4·HCl分子量:
397.8284
InChI:
InChI=1/C18H20FN3O4.ClH/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H/t10-;/m0./s1
沸點:
571.5°C at 760 mmHg
閃點:
299.4°C
適用于敏感菌引起的泌尿系統感染,包括單純性、復雜性尿路感染、細菌性前列腺炎、淋 病奈瑟菌尿道炎或宮頸炎(包括產酶株所致者)。
含量98%  ***左氧氟沙星原料藥廠家  價格:257/Kg
©2025 湖北遠成賽創科技有限公司孝感分公司 版權所有   技術支持:化工網   訪問量:18652  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |